BenevolentAI’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

BenevolentAI develops an AI-based platform to identify new drug candidates for the treatment of neuro disorders. Read more

47 Followers on Owler
47 Followers on Owler
47 Followers on Owler
47 Followers on Owler

BenevolentAI develops an AI-based platform to identify new drug candidates for the treatment of neuro disorders. Read more

Joanna Shields's photo - CEO of BenevolentAI

CEO

Joanna Shields

CEO Approval Rating

89/100

Founded:

2013

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Cyclica is a top competitor of BenevolentAI. Cyclica was founded in Toronto, Ontario} in 2010. Cyclica competes in the Health Care Technology industry. Compared to BenevolentAI, Cyclica generates $3M more revenue.

TwoXAR is BenevolentAI's #2 competitor. TwoXAR is headquartered in Mountain View, California, and was founded in 2014. TwoXAR operates in the Biotechnology industry. TwoXAR generates 262% the revenue of BenevolentAI.

Exscientia Ltd. has been one of BenevolentAI's top competitors. Exscientia Ltd. is a Private company that was founded in 2012 in Dundee, Scotland. Like BenevolentAI, Exscientia Ltd. also competes in the Health Care Technology industry. Compared to BenevolentAI, Exscientia Ltd. has 115 fewer employees.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 165 a good estimate for BenevolentAI's Employee count?

Acquisitions

No recent acquisitions found related to BenevolentAI

BenevolentAI Funding History

$87.7M$207.7M$297.7M

Since BenevolentAI was founded in 2013, it has participated in 3 rounds of funding. In total BenevolentAI has raised $297.7M. BenevolentAI's last funding round was on Sep 2019 for a total of $90.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Sep 2019
$90M

Temasek

Equity
Apr 2018
$120M
Unattributed
Oct 2014
$87.7M

Since BenevolentAI was founded in 2013, it has participated in 3 rounds of funding. In total BenevolentAI has raised $297.7M. BenevolentAI's last funding round was on Sep 2019 for a total of $90.0M

Investments

No recent investments found related to BenevolentAI

BenevolentAI News

February 12, 2020FirstWord Pharma

BenevolentAI announces scientific collaboration with UC San Diego to investigate Cerebral Cavernous Malformations

BenevolentAI, the leader in the creation and application of AI and machine learning to transform the ... See more »
October 17, 2019Global Legal Chronicle

Temasek's $90 Million Investment in BenevolentAI

Covington advised BenevolentAI on the deal. Temasek, a Singapore-headquartered investment company, ex... See more »
September 17, 2019FE Investegate

BenevolentAI

3:11 PM: (WPCT) BenevolentAI... See more »
September 17, 2019Benevolent

BenevolentAI announces $90 million investment from Temasek

BenevolentAI, the leader in the creation and application of AI and machine learning to transform the ... See more »
September 16, 2019Investmentweek

Woodford holding Benevolent AI sees valuation halve

One of Neil Woodford's main holdings, Benevolent AI, is set to see its valuation halve on the back of... See more »
September 6, 2019The Pharma Letter

BenevolentAI inks new collaboration deal with big pharma

BenevolentAI, a UK artificial intelligence (AI) company focused on health and drug development, has a... See more »
August 5, 2019firstwordpharma

Neuropore Therapies and BenevolentAI Enter Strategic Collaboration to Discover Novel Therapeutics Through the Application of Artificial Intelligence

Neuropore Therapies and BenevolentAI Enter Strategic Collaboration to Discover Novel Therapeutics Thr... See more »

BenevolentAI Blogs

March 8, 2020BenevolentAI Blog

How historically neglecting sex differences has impacted women's health

Sex differences have historically been neglected in clinical research, design and practice. To mark I... See more »
March 3, 2020BenevolentAI Blog

Medical data: the key to unlocking the true potential of AI in healthcare

The biomedical research data-gap risks worsening health inequality, and will be exacerbated in the a... See more »
February 27, 2020BenevolentAI Blog

Teaming up to fuel scientific discovery in CCM research

We partnered with UC San Diego to investigate new approaches to develop non-invasive therapeutic tre... See more »
February 26, 2020BenevolentAI Blog

MIT Technology Review names BenevolentAI as a top 10 breakthrough tech

We're proud to be recognised on this prestigious list for our work in AI-driven chemical design. Our ... See more »
February 7, 2020BenevolentAI Blog

Working together to meet a 'moonshot moment' in drug discovery and development

Joanna Shields addresses AstraZeneca's scientists and explains how true collaboration between human e... See more »
February 6, 2020BenevolentAI Blog

One team, one mission: nurturing a culture of innovation and collaboration

Like all fast-growth companies, we face the challenge of balancing the need to build and scale qualit... See more »
November 18, 2019BenevolentAI Blog

Introducing our latest research at NeurIPS2019

Machine learning and artificial intelligence represent an incredible opportunity for the health secto... See more »

BenevolentAI Videos

Social Media

Headquarters

4-8 Maple Street

London, EnglandW1T 5HD

44-2037-819-360

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

BenevolentAI develops an AI-based platform to identify new drug candidates for the treatment of neuro disorders. BenevolentAI was founded in 2013. BenevolentAI's headquarters is located in London, England, GB W1T 5HD. It has raised 297.7M in 3 rounds....

CEO

BenevolentAI's CEO, Joanna Shields, currently has an approval rating of 89%. BenevolentAI's primary competitors are Cyclica, TwoXAR & Exscientia Ltd..

Website

benevolent.ai

Frequently Asked Questions about BenevolentAI

  1. When was BenevolentAI founded?

    BenevolentAI was founded in 2013
  2. Who is BenevolentAI's CEO?

    BenevolentAI's CEO is Joanna Shields
  3. How much revenue does BenevolentAI generate?

    BenevolentAI generates $2M in revenue
  4. How much funding does BenevolentAI have?

    BenevolentAI has historically raised $297.7M in funding
  1. Where is BenevolentAI's headquarters?

    BenevolentAI's headquarters is in London England, GB
  2. How many employees does BenevolentAI have?

    BenevolentAI has 165 employees
  3. What sector does BenevolentAI operate in?

    BenevolentAI is in Health Care Technology
  4. Who are BenevolentAI's competitors?

    BenevolentAI's top competitors are Cyclica, TwoXAR, Exscientia Ltd.